未登录

M

Marion Ehrich

university of florida

H指数:36

被引数:4,403

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hybrid-nanoparticle based oxycodone vaccines: impact of carrier proteins and adjuvants on their immunogenicity

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-010

PRE

The immunological and pharmacokinetic evaluation of Lipid-PLGA hybrid nanoparticle-based oxycodone vaccines

IF12.9

2025-02-011

PRE

Human blood markers of cholinergic neurotoxicity and neuropathy: A useful guide for laboratory applications

NEUROTOXICOLOGY

IF3.9

2024-03-011

PRE

Formulation of Nanovaccines toward an Extended Immunity against Nicotine

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2021-06-098

OAAI

Effects of polyhydroxyfullerenes on organophosphate-induced toxicity in mice

IF4.6

2020-12-011

OAAI

Studies Exploring the Interaction of the Organophosphorus Compound Paraoxon with Fullerenes

IF4.3

2019-10-283

OAAI

Exploratory studies with NX-13: oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1

DRUG AND CHEMICAL TOXICOLOGY

IF1.9

2019-10-2516

OAAI

Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines

IF12.9

2018-11-0120

OAAI

Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction

IF12.9

2018-02-0139

OAAI

Synthesis and Evaluation of Doxorubicin-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery

BIOCONJUGATE CHEMISTRY

IF3.9

2018-01-1193

PREAI

Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization

IF12.9

2017-09-0123

OAAI

Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY

IF8.2

2016-11-08101

OAAI

The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine

IF12.9

2016-11-0132

OAAI

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease

INTERNATIONAL JOURNAL OF TOXICOLOGY

IF1

2016-07-0919

OAAI

Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability

ACTA BIOMATERIALIA

IF9.6

2015-12-0169

OAAI

Lanthionine Synthetase C-Like Receptor 2 (LANCL2): A Novel Therapeutic Target for Inflammatory Bowel Disease

GASTROENTEROLOGY

IF25.1

2015-04-016

PREAI

In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters

NANOSCALE RESEARCH LETTERS

IF4.1

2014-08-2744

OAAI

Biochemical, histopathological and clinical evaluation of delayed effects caused by methamidophos isoforms and TOCP in hens: Ameliorative effects using control of calcium homeostasis

IF4.6

2012-12-0124

OAAI

Liver enzymes in White Leghorns selected for the sheep red blood cell immune response

POULTRY SCIENCE

IF4.2

2012-02-0116

OAAI

Comparative in vitro study of the inhibition of human and hen esterases by methamidophos enantiomers

IF4.6

2012-02-0126

OAAI